Delivery Order SPE2DB22D1017-SPE2DB25FF9GW

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication, with a ceiling value of $4,356.80 and a period of performance through April 2, 2025. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CARVEDILOL ER 10 MG CAPSULE 30S. The contract is a Delivery Order with a Firm Fixed Price of $4,087.67 and a period of performance through February 11, 2025. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication, with a ceiling value of $4,118.28 and a performance period ending on November 3, 2023. This award is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CARVEDILOL ER 40 MG CAPSULES 30S, a cardiovascular medication. The award has a ceiling value of $9,050.18 and a completion date of March 31, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,164.72 firm-fixed-price contract is for the delivery of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The contract has a completion date of June 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication, with a ceiling value of $2,515.44. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 2, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,198.19 firm fixed-price delivery order is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of February 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,540.62 firm fixed-price delivery order is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,498.28 firm fixed price delivery order is for the supply of CARVEDILOL ER 10 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of CARVEDILOL ER 10 MG CAPSULES 30S, a cardiovascular medication, with a ceiling value of $10,876.56. The contract is a Firm Fixed Price Delivery Order, with a performance period extending through June 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF9GW
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CARVEDILOL ER 10 MG CAPSULE 30S, a cardiovascular medication, with a ceiling value of $3,860.04 and an ultimate completion date of April 4, 2025.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about major subcontractors. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 7/3/25, 2:48 PM